speb/financial-data huggingface dataset:
AGEN income_statement (annual, 2023-12-31) — Gross Profit: -81366000.00
AGEN income_statement (annual, 2023-12-31) — Interest Expense: 97925000.00
AGEN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 97925000.00
AGEN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3168000.00
AGEN balance_sheet (annual, 2023-12-31) — Invested Capital: -147417000.00
AGEN cash_flow (annual, 2023-12-31) — Investing Cash Flow: 3400000.00
AGEN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 133157000.00
AGEN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
AGEN balance_sheet (annual, 2023-12-31) — Land And Improvements: 12286000.00
AGEN balance_sheet (annual, 2023-12-31) — Leases: 95645000.00
AGEN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 62511000.00
AGEN balance_sheet (annual, 2023-12-31) — Long Term Debt: 12768000.00
AGEN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 75279000.00
AGEN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
AGEN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -8926000.00
AGEN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 80084000.00
AGEN balance_sheet (annual, 2023-12-31) — Minority Interest: 11949000.00
AGEN income_statement (annual, 2023-12-31) — Minority Interests: 11676000.00
AGEN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
AGEN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 127985000.00
AGEN income_statement (annual, 2023-12-31) — Net Income: -245761000.00
AGEN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -245974000.00
AGEN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -257437000.00
AGEN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -245761000.00
AGEN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -245761000.00
AGEN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -257437000.00
AGEN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -257437000.00
AGEN income_statement (annual, 2023-12-31) — Net Interest Income: -97925000.00
AGEN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 9991000.00
AGEN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -8926000.00
AGEN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -8926000.00
AGEN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -97925000.00
AGEN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -606000.00
AGEN balance_sheet (annual, 2023-12-31) — Net PPE: 163027000.00
AGEN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -6591000.00
AGEN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -189465000.00
AGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (annual, 2023-12-31) — Normalized EBITDA: -146480000.00
AGEN income_statement (annual, 2023-12-31) — Normalized Income: -246317000.00
AGEN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -224202000.00
AGEN cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1964000.00
AGEN income_statement (annual, 2023-12-31) — Operating Income: -160105000.00
AGEN income_statement (annual, 2023-12-31) — Operating Revenue: 41742000.00
AGEN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 19718662.00
AGEN balance_sheet (annual, 2023-12-31) — Other Current Assets: 2372000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 141210000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -955000.00
AGEN income_statement (annual, 2023-12-31) — Other Gand A: 78739000.00
AGEN income_statement (annual, 2023-12-31) — Other Income Expense: 593000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 4411000.00
AGEN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -14140000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 9336000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 129976000.00
AGEN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 37000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Properties: 29606000.00
AGEN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
AGEN balance_sheet (annual, 2023-12-31) — Payables: 61446000.00
AGEN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 101479000.00
AGEN balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
AGEN income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 213000.00
AGEN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 8098000.00
AGEN income_statement (annual, 2023-12-31) — Pretax Income: -257437000.00
AGEN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 807000.00
AGEN balance_sheet (annual, 2023-12-31) — Properties: 0.00
AGEN cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
AGEN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -20043000.00
AGEN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -9954000.00
AGEN balance_sheet (annual, 2023-12-31) — Receivables: 25836000.00
AGEN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 237680000.00
AGEN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 13588000.00
AGEN cash_flow (annual, 2023-12-31) — Repayment Of Debt: -8926000.00
AGEN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -5172000.00
AGEN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -556000.00
AGEN balance_sheet (annual, 2023-12-31) — Retained Earnings: -1955668000.00
AGEN cash_flow (annual, 2023-12-31) — Sale Of Investment: 30034000.00
AGEN cash_flow (annual, 2023-12-31) — Sale Of PPE: 3363000.00
AGEN income_statement (annual, 2023-12-31) — Selling General And Administration: 78739000.00
AGEN balance_sheet (annual, 2023-12-31) — Share Issued: 19718662.00
AGEN income_statement (annual, 2023-12-31) — Special Income Charges: 556000.00
AGEN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 22869000.00
AGEN balance_sheet (annual, 2023-12-31) — Stockholders Equity: -160331000.00
AGEN balance_sheet (annual, 2023-12-31) — Tangible Book Value: -189465000.00
AGEN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
AGEN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
AGEN balance_sheet (annual, 2023-12-31) — Total Assets: 313913000.00
AGEN balance_sheet (annual, 2023-12-31) — Total Capitalization: -147563000.00
AGEN balance_sheet (annual, 2023-12-31) — Total Debt: 88469000.00
AGEN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -148382000.00
AGEN income_statement (annual, 2023-12-31) — Total Expenses: 316419000.00
AGEN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 462295000.00
AGEN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 201497000.00
AGEN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 206398000.00
AGEN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -159549000.00
AGEN income_statement (annual, 2023-12-31) — Total Unusual Items: 556000.00
AGEN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 556000.00
AGEN balance_sheet (annual, 2023-12-31) — Treasury Stock: 0.00
AGEN cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 2126000.00
AGEN balance_sheet (annual, 2023-12-31) — Working Capital: -143481000.00
AGEN income_statement (quarterly, 2024-09-30) — Basic Average Shares: 21550000.00
AGEN income_statement (quarterly, 2024-09-30) — Basic EPS: -3.08
AGEN cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -7000.00
AGEN income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 21822727.00
AGEN income_statement (quarterly, 2024-09-30) — Diluted EPS: -3.08
AGEN income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 0.00
AGEN income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 1863000.00
AGEN cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
AGEN cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 9000.00
AGEN cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: 0.00
AGEN income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
AGEN income_statement (annual, 2024-12-31) — +Operating Expense: 71878000.00
AGEN income_statement (annual, 2024-12-31) — +Total Revenue: 103463000.00
AGEN balance_sheet (annual, 2024-12-31) — Accounts Payable: 61470000.00
AGEN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 407000.00
AGEN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -72553000.00
AGEN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1857662000.00
AGEN cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1973000.00
AGEN balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
AGEN income_statement (annual, 2024-12-31) — Basic Average Shares: 21473000.00
AGEN income_statement (annual, 2024-12-31) — Basic EPS: -10.59
AGEN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 79779000.00
AGEN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 5837000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 5837000.00
AGEN cash_flow (annual, 2024-12-31) — Capital Expenditure: -576000.00
AGEN cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -73000.00
AGEN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 61699000.00
AGEN balance_sheet (annual, 2024-12-31) — Capital Stock: 236000.00
AGEN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 40437000.00
AGEN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 40437000.00
AGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 122840000.00
AGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 27000.00
AGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -158315000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Account Payable: 2013000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 136000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -671000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Payable: 2013000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2149000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 5782000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Receivables: 25344000.00
AGEN cash_flow (annual, 2024-12-31) — Change In Working Capital: 32604000.00
AGEN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 25344000.00
AGEN cash_flow (annual, 2024-12-31) — Changes In Cash: -35448000.00
AGEN balance_sheet (annual, 2024-12-31) — Common Stock: 236000.00
AGEN balance_sheet (annual, 2024-12-31) — Common Stock Equity: -326380000.00
AGEN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 38823000.00
AGEN cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
AGEN balance_sheet (annual, 2024-12-31) — Construction In Progress: 784000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 784000.00
AGEN income_statement (annual, 2024-12-31) — Cost Of Revenue: 156014000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 28202000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Assets: 45574000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7148000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Debt: 2698000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 9846000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 31000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 31000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 31000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 31000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Liabilities: 221401000.00
AGEN balance_sheet (annual, 2024-12-31) — Current Notes Payable: 146000.00
AGEN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 13343000.00
AGEN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 13343000.00
AGEN income_statement (annual, 2024-12-31) — Diluted Average Shares: 21473000.00
AGEN income_statement (annual, 2024-12-31) — Diluted EPS: -10.59
AGEN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -227427000.00
AGEN balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Non Current: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Non Current: 0.00
AGEN income_statement (annual, 2024-12-31) — EBIT: -114645000.00
AGEN income_statement (annual, 2024-12-31) — EBITDA: -101302000.00
AGEN income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
AGEN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -260000.00
AGEN cash_flow (annual, 2024-12-31) — End Cash Position: 44071000.00
AGEN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 122840000.00
AGEN cash_flow (annual, 2024-12-31) — Free Cash Flow: -158891000.00
AGEN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -3954000.00
AGEN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
AGEN income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
AGEN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1398000.00
AGEN income_statement (annual, 2024-12-31) — General And Administrative Expense: 71878000.00
AGEN balance_sheet (annual, 2024-12-31) — Goodwill: 24092000.00
AGEN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 27468000.00
AGEN balance_sheet (annual, 2024-12-31) — Gross PPE: 219948000.00
AGEN income_statement (annual, 2024-12-31) — Gross Profit: -52551000.00
AGEN income_statement (annual, 2024-12-31) — Interest Expense: 117626000.00
AGEN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 117626000.00
AGEN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2278000.00
AGEN balance_sheet (annual, 2024-12-31) — Invested Capital: -293209000.00
AGEN cash_flow (annual, 2024-12-31) — Investing Cash Flow: 27000.00
AGEN balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
AGEN balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
AGEN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 38823000.00
AGEN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 20000000.00
AGEN balance_sheet (annual, 2024-12-31) — Land And Improvements: 12286000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 12286000.00
AGEN balance_sheet (annual, 2024-12-31) — Leases: 94860000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Leases: 94860000.00
AGEN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 54551000.00
AGEN balance_sheet (annual, 2024-12-31) — Long Term Debt: 30473000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 30473000.00
AGEN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 85024000.00
AGEN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 20000000.00
AGEN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -10481000.00
AGEN balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
AGEN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 78873000.00
AGEN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 78873000.00
AGEN balance_sheet (annual, 2024-12-31) — Minority Interest: 19956000.00
AGEN income_statement (annual, 2024-12-31) — Minority Interests: 5059000.00
AGEN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
AGEN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 38823000.00
AGEN income_statement (annual, 2024-12-31) — Net Income: -227212000.00
AGEN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -227427000.00
AGEN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -232271000.00
AGEN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -227212000.00
AGEN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -227212000.00
AGEN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -232271000.00
AGEN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -232271000.00
AGEN income_statement (annual, 2024-12-31) — Net Interest Income: -117626000.00
AGEN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 579000.00
AGEN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 9519000.00
AGEN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 9519000.00
AGEN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -117626000.00
AGEN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 73851000.00
AGEN cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
AGEN balance_sheet (annual, 2024-12-31) — Net PPE: 147395000.00
AGEN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -552000.00
AGEN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -353848000.00
AGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (annual, 2024-12-31) — Normalized EBITDA: -105256000.00
AGEN income_statement (annual, 2024-12-31) — Normalized Income: -231166000.00
AGEN balance_sheet (annual, 2024-12-31) — Notes Receivable: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 0.00
AGEN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -158315000.00
AGEN cash_flow (annual, 2024-12-31) — Operating Gains Losses: -4589000.00
AGEN cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -4607000.00
AGEN income_statement (annual, 2024-12-31) — Operating Income: -124429000.00
AGEN income_statement (annual, 2024-12-31) — Operating Revenue: 2485000.00
AGEN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 23634670.00
AGEN balance_sheet (annual, 2024-12-31) — Other Current Assets: 2415000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 2552000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 121852000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1398000.00
AGEN income_statement (annual, 2024-12-31) — Other Gand A: 71878000.00
AGEN income_statement (annual, 2024-12-31) — Other Income Expense: 9784000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 3376000.00
AGEN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 11693000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5834000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 225127000.00
AGEN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 5830000.00
AGEN balance_sheet (annual, 2024-12-31) — Other Properties: 27308000.00
AGEN balance_sheet (annual, 2024-12-31) — Payables: 61470000.00
AGEN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 89672000.00
AGEN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
AGEN income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 215000.00
AGEN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2315000.00
AGEN income_statement (annual, 2024-12-31) — Pretax Income: -232271000.00
AGEN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 647000.00
AGEN balance_sheet (annual, 2024-12-31) — Properties: 0.00
AGEN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
AGEN cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
AGEN cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
AGEN cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
AGEN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -576000.00
AGEN balance_sheet (annual, 2024-12-31) — Receivables: 407000.00
AGEN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 156014000.00
AGEN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 13343000.00
AGEN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -10481000.00
AGEN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
AGEN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -3954000.00
AGEN balance_sheet (annual, 2024-12-31) — Retained Earnings: -2182880000.00
AGEN cash_flow (annual, 2024-12-31) — Sale Of Investment: 579000.00
AGEN cash_flow (annual, 2024-12-31) — Sale Of PPE: 24000.00
AGEN income_statement (annual, 2024-12-31) — Selling General And Administration: 71878000.00
AGEN balance_sheet (annual, 2024-12-31) — Share Issued: 23634670.00
AGEN income_statement (annual, 2024-12-31) — Special Income Charges: 3954000.00
AGEN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 17390000.00
AGEN balance_sheet (annual, 2024-12-31) — Stockholders Equity: -326380000.00
AGEN balance_sheet (annual, 2024-12-31) — Tangible Book Value: -353848000.00
AGEN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AGEN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
AGEN balance_sheet (annual, 2024-12-31) — Total Assets: 226271000.00
AGEN balance_sheet (annual, 2024-12-31) — Total Capitalization: -295907000.00
AGEN balance_sheet (annual, 2024-12-31) — Total Debt: 94870000.00
AGEN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -306424000.00
AGEN income_statement (annual, 2024-12-31) — Total Expenses: 227892000.00
AGEN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 532695000.00
AGEN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 180697000.00
AGEN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 311294000.00
AGEN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -120475000.00
AGEN income_statement (annual, 2024-12-31) — Total Unusual Items: 3954000.00
AGEN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 3954000.00
AGEN cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 1542000.00
AGEN balance_sheet (annual, 2024-12-31) — Working Capital: -175827000.00
AGEN income_statement (quarterly, 2025-03-31) — +Operating Expense: 15718000.00
AGEN income_statement (quarterly, 2025-03-31) — +Total Revenue: 24066000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 64240000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 354000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -75878000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1867500000.00
AGEN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 24469000.00
AGEN income_statement (quarterly, 2025-03-31) — Basic EPS: -1.03
AGEN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 44071000.00
AGEN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -5000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 58466000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 266000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 18488000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 18488000.00
AGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3594000.00
AGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 57000.00
AGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -25618000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2642000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1379000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 348000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Payable: 2642000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 4021000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 443000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 108000.00
AGEN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 4920000.00
AGEN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 108000.00
AGEN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -21967000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Common Stock: 266000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -341848000.00
AGEN cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 6343000.00
AGEN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -22000.00
AGEN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 21659000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 29568000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Assets: 23138000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 4484000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Debt: 731000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5215000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 14000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 14000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 208304000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 146000.00
AGEN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3203000.00
AGEN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3203000.00
AGEN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 24469000.00
AGEN income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.03
AGEN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -25320000.00
AGEN income_statement (quarterly, 2025-03-31) — EBIT: -13575000.00
AGEN income_statement (quarterly, 2025-03-31) — EBITDA: -10372000.00
AGEN income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
AGEN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 18000.00
AGEN cash_flow (quarterly, 2025-03-31) — End Cash Position: 22122000.00
AGEN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3594000.00
AGEN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -25623000.00
AGEN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 0.00
AGEN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1468000.00
AGEN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 15718000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Goodwill: 24092000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 27383000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 219954000.00
AGEN income_statement (quarterly, 2025-03-31) — Gross Profit: 2407000.00
AGEN income_statement (quarterly, 2025-03-31) — Interest Expense: 12795000.00
AGEN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 12795000.00
AGEN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 387000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Invested Capital: -308271000.00
AGEN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 57000.00
AGEN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 6343000.00
AGEN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 2500000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 53982000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 32846000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 86828000.00
AGEN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 2500000.00
AGEN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -5271000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Minority Interest: 19450000.00
AGEN income_statement (quarterly, 2025-03-31) — Minority Interests: 1104000.00
AGEN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 6321000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Net Debt: 15089000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Income: -25266000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -25320000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -26370000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -25266000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -25266000.00
AGEN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -26370000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -26370000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Interest Income: -12795000.00
AGEN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 62000.00
AGEN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2771000.00
AGEN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2771000.00
AGEN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -12795000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Net PPE: 144076000.00
AGEN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -369231000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -10372000.00
AGEN income_statement (quarterly, 2025-03-31) — Normalized Income: -25266000.00
AGEN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -25618000.00
AGEN income_statement (quarterly, 2025-03-31) — Operating Income: -13311000.00
AGEN income_statement (quarterly, 2025-03-31) — Operating Revenue: 510000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 26563545.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2424000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 585000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 109267000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1468000.00
AGEN income_statement (quarterly, 2025-03-31) — Other Gand A: 15718000.00
AGEN income_statement (quarterly, 2025-03-31) — Other Income Expense: -264000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 3291000.00
AGEN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -10946000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5604000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 226324000.00
AGEN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -264000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Other Properties: 219954000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Payables: 64240000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 93808000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
AGEN income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 54000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1872000.00
AGEN income_statement (quarterly, 2025-03-31) — Pretax Income: -26370000.00
AGEN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 44000.00
AGEN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Receivables: 354000.00
AGEN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 21659000.00
AGEN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3203000.00
AGEN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -5271000.00
AGEN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -22000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -2208146000.00
AGEN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 62000.00
AGEN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
AGEN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 15718000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Share Issued: 26563545.00
AGEN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
AGEN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3482000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -341848000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -369231000.00
AGEN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AGEN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Assets: 200201000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -309002000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Debt: 92043000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -322398000.00
AGEN income_statement (quarterly, 2025-03-31) — Total Expenses: 37377000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 522599000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 177063000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 314295000.00
AGEN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -13311000.00
AGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
AGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AGEN cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 93000.00
AGEN balance_sheet (quarterly, 2025-03-31) — Working Capital: -185166000.00
AGEN income_statement (quarterly, 2025-06-30) — +Operating Expense: 15518000.00
AGEN income_statement (quarterly, 2025-06-30) — +Total Revenue: 25691000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 74396000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 709000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -74782000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1882704000.00
AGEN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 28117000.00
AGEN income_statement (quarterly, 2025-06-30) — Basic EPS: -1.00
AGEN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 22122000.00
AGEN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 56656000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 300000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 9534000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 9534000.00
AGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 10942000.00
AGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 281000.00
AGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -20222000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 10064000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2851000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 594000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Payable: 10064000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 12915000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 537000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -340000.00
AGEN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 13706000.00
AGEN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -340000.00
AGEN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -8999000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Common Stock: 300000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -354601000.00
AGEN cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 12217000.00
AGEN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -65000.00
AGEN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 26953000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 31988000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Assets: 13340000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3262000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Debt: 10721000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 13983000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 45000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 45000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 234563000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 146000.00
AGEN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3168000.00
AGEN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3168000.00
AGEN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 28117000.00
AGEN income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.00
AGEN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -28009000.00
AGEN income_statement (quarterly, 2025-06-30) — EBIT: -16723000.00
AGEN income_statement (quarterly, 2025-06-30) — EBITDA: -13555000.00
AGEN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 45000.00
AGEN cash_flow (quarterly, 2025-06-30) — End Cash Position: 13168000.00
AGEN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 10942000.00
AGEN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -20223000.00
AGEN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 69000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1504000.00
AGEN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 15518000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Goodwill: 24092000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 27298000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 213925000.00
AGEN income_statement (quarterly, 2025-06-30) — Gross Profit: -1262000.00
AGEN income_statement (quarterly, 2025-06-30) — Interest Expense: 13289000.00
AGEN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 13289000.00
AGEN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 258000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Invested Capital: -320729000.00
AGEN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 281000.00
AGEN cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 12217000.00
AGEN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
AGEN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 53394000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 23151000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 76545000.00
AGEN cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
AGEN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1210000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Minority Interest: 18293000.00
AGEN income_statement (quarterly, 2025-06-30) — Minority Interests: 2057000.00
AGEN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 12152000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Net Debt: 24338000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Income: -27955000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -28009000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -30012000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -27955000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -27955000.00
AGEN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -30012000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -30012000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Interest Income: -13289000.00
AGEN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
AGEN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1210000.00
AGEN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1210000.00
AGEN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -13289000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Net PPE: 139143000.00
AGEN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 281000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -381899000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1143000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1143000.00
AGEN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -13624000.00
AGEN income_statement (quarterly, 2025-06-30) — Normalized Income: -28024000.00
AGEN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -20222000.00
AGEN income_statement (quarterly, 2025-06-30) — Operating Income: -16780000.00
AGEN income_statement (quarterly, 2025-06-30) — Operating Revenue: 860000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 30004430.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1760000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 10575000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 114151000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1504000.00
AGEN income_statement (quarterly, 2025-06-30) — Other Gand A: 15518000.00
AGEN income_statement (quarterly, 2025-06-30) — Other Income Expense: 57000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 3206000.00
AGEN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -11505000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5440000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 209278000.00
AGEN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -12000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Other Properties: 213925000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Payables: 74396000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 106384000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
AGEN income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 54000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1337000.00
AGEN income_statement (quarterly, 2025-06-30) — Pretax Income: -30012000.00
AGEN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
AGEN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Receivables: 709000.00
AGEN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 26953000.00
AGEN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3168000.00
AGEN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1210000.00
AGEN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -65000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -2236101000.00
AGEN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
AGEN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 282000.00
AGEN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15518000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Share Issued: 30004430.00
AGEN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3585000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -354601000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -381899000.00
AGEN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AGEN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Assets: 185221000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -331450000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Debt: 90528000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -336308000.00
AGEN income_statement (quarterly, 2025-06-30) — Total Expenses: 42471000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 521529000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 171881000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 286966000.00
AGEN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -16711000.00
AGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items: 69000.00
AGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 69000.00
AGEN balance_sheet (quarterly, 2025-06-30) — Working Capital: -221223000.00
AGEN income_statement (quarterly, 2025-09-30) — +Operating Expense: 10860000.00
AGEN income_statement (quarterly, 2025-09-30) — +Total Revenue: 30235000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 85289000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 538000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -47166000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1899281000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 122149000.00
AGEN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 31886000.00
AGEN income_statement (quarterly, 2025-09-30) — Basic EPS: 2.00
AGEN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 13168000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11561000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 329000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3458000.00
AGEN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3458000.00
AGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 6683000.00
AGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 76000.00
AGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -14737000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 14134000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 9205000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -11184000.00
AGEN cash_flow (quarterly, 2025-09-30) — Change In Payable: 14134000.00